The EMINENCE Study - PET/MR Imaging of Head Neck Cancer

Recruiting now

Conditions studied: Head and Neck Neoplasms

In brief

Head and neck cancers (HNC) often receive radiotherapy as part of their treatment. However, unacceptable failure rates and severe side effects remain a challenge. The improvements in radiotherapy are closely related to improvements in medical imaging. Functional imaging, where intratumoural characteristics such as tumour oxygenation, metabolism, and blood vessel function can be quantified, offers possibilities to personalize the radiotherapy. In this study we will establish the clinical workflow for PET- and MRI-based radiotherapy in HNC by acquiring images prior to and during radiotherapy to develop new concepts for image-based biologically adaptive radiotherapy, both based on photon-based radiotherapy and also proton therapy, which soon will be available for cancer patients in Norway. The investigators aim to contribute towards further developments of personalised high-precision radiotherapy for HNC patients resulting in improved outcome, reduced side-effects and better quality of life.

Key facts

Study ID

NCT04612075

Run by

Norwegian University of Science and Technology

People needed

390

Starts

2021-01-12

Expected to finish

2028-12-01

Last updated by the study team

2026-04-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• willing and able to give full written consent according to the protocol approved by the Regional Ethics Committee
• histologically confirmed squamous cell carcinoma in the head neck region (pharynx, larynx, oral cavity or sinonasal area)
• locally advanced disease without sign of dissemination (T3/T4 and/or N1-3, M0) on diagnostic imaging
• scheduled for definitive radiotherapy with curative intent with or without concomitant chemotherapy
• adequate renal function: Creatinine clearance ≥ 60 ml/minute
• lymph node metastasis from cancer of unknown primary of the upper neck (i.e. level II-III) were PET/CT is negative outside the head-neck region can be considered for inclusion at the discretion of the study investigators.

You may not qualify if…

• general contraindications for MRI (pacemaker, aneurysm clips, any form of metal in the body, severe claustrophobia)
• serious comorbidity (including previous or othe cancer) that in the opinion of the investigator would compromise the patient's ability to complete the study of interfere with the evaluation of the study objectives (e.g. poorly controlled diabetes mellitus)
• histologically confirmed SCC of same or other origin within the last five years
• patient wants to withdraw for any reason during the study

Where it is running

• St Olavs Hospital, Department of Oncology — Trondheim, Norway (enrolling)
• University Hospital of North Norway — Tromsø, Norway

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.